| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA926687 | A | Oral bioavailability in human | Homo sapiens | 295 | ALA1141299 | organism-based format | Scientific Literature | |
| 2. | ALA929914 | B | Inhibition of PAD4 by ABPP-based assay | 14 | ALA1143172 | single protein format | Scientific Literature | ||
| 3. | ALA929915 | B | Inhibition of PAD4 measured by slope plot of Lineweaver-Burke analyses | 3 | ALA1143172 | single protein format | Scientific Literature | ||
| 4. | ALA929916 | B | Inhibition of PAD4 measured by intercept plot of Lineweaver-Burke analyses | 3 | ALA1143172 | single protein format | Scientific Literature | ||
| 5. | ALA995340 | B | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor | Homo sapiens | 49 | ALA1136967 | assay format | Scientific Literature | |
| 6. | ALA995341 | B | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM | Homo sapiens | 26 | ALA1136967 | assay format | Scientific Literature | |
| 7. | ALA1016072 | F | Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method | Mycoplasma putrefaciens | 15 | ALA1154426 | organism-based format | Scientific Literature | |
| 8. | ALA1016073 | F | Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method | Mycoplasma putrefaciens | 15 | ALA1154426 | organism-based format | Scientific Literature | |
| 9. | ALA1016074 | F | Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method | Mycoplasma putrefaciens | 15 | ALA1154426 | organism-based format | Scientific Literature | |
| 10. | ALA965578 | B | Inhibition of mouse brain MAOA | Mus musculus | 385 | ALA1152129 | assay format | Scientific Literature | |
| 11. | ALA965582 | B | Inhibition of bovine brain MAOA | Bos taurus | 92 | ALA1152129 | assay format | Scientific Literature | |
| 12. | ALA965584 | B | Inhibition of bovine brain MAOB | Bos taurus | 56 | ALA1152129 | assay format | Scientific Literature | |
| 13. | ALA1046150 | A | Permeability at pH 6.5 by PAMPA method | 33 | ALA1156784 | assay format | Scientific Literature | ||
| 14. | ALA1046151 | A | Oral bioavailability in human | Homo sapiens | 33 | ALA1156784 | organism-based format | Scientific Literature | |
| 15. | ALA1614670 | A | Volume of distribution at steady state in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
| 16. | ALA1614671 | A | Clearance in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
| 17. | ALA1614672 | A | Fraction unbound in human after iv administration | Homo sapiens | 554 | ALA1614632 | organism-based format | Scientific Literature | |
| 18. | ALA1614673 | A | Mean residence time in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
| 19. | ALA1614674 | A | Half life in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
| 20. | ALA1615361 | A | Phospholipidosis-negative literature compound | 61 | ALA1615345 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!